WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Consensus
Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
CPRX
CATALYST PHARMACEUTICALS INC
$682.46M$6.64$11.6074.70%Strong Buy517.24%26.47%42.94%38.29%
HALO
HALOZYME THERAPEUTICS INC
$6.47B$46.90$53.0013.01%Buy226.73%9.13%276.16%61.84%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$3.05B$51.67$58.2512.73%Strong Buy431.43%66.12%136.26%62.99%
SESN
SESEN BIO INC
$163.16M$0.82N/AN/AHold124.42%N/A-25.40%-19.43%
EXEL
EXELIXIS INC
$7.13B$22.22$32.0044.01%Strong Buy712.36%18.31%28.11%24.29%
INCY
INCYTE CORP
$17.32B$78.19$86.1410.17%Buy714.21%11.29%47.88%36.59%
MRNA
MODERNA INC
$57.38B$144.27$241.3067.26%Buy11-38.81%N/A24.20%14.97%
UTHR
UNITED THERAPEUTICS CORP
$10.82B$238.95$236.57-1.00%Strong Buy88.78%10.16%24.97%19.46%
CLNN
CLENE INC
$183.44M$2.90$10.00244.83%Strong Buy1593.79%37.51%29,824.97%1,127.36%
REGN
REGENERON PHARMACEUTICALS INC
$67.28B$612.49$717.0017.06%Buy15-7.95%-16.34%24.64%18.63%
CRSP
CRISPR THERAPEUTICS AG
$5.19B$66.96$103.9255.20%Buy14-10.77%N/A11.21%9.66%
CDMO
AVID BIOSERVICES INC
$963.83M$15.61$31.67102.86%Buy434.56%101.56%70.94%12.78%
GMAB
GENMAB A
$21.24B$32.31$37.3515.59%Hold829.45%45.00%4.79%4.36%
VRTX
VERTEX PHARMACEUTICALS INC
$74.82B$292.55$268.83-8.11%Buy137.31%14.07%34.47%26.37%
XOMA
XOMA CORP
$237.56M$20.80$49.00135.58%Buy38.62%0.38%25.47%22.39%
AVIR
ATEA PHARMACEUTICALS INC
$593.63M$7.13$8.0012.20%Sell310.62%3.76%2.45%2.32%
CORT
CORCEPT THERAPEUTICS INC
$2.53B$23.80$30.0026.05%Strong Buy29.29%6.62%39.08%34.05%
LJPC
LA JOLLA PHARMACEUTICAL CO
$88.42M$3.46$4.0015.61%Hold113.43%32.16%-25.01%18.30%
TECH
BIO-TECHNE CORP
$13.84B$352.76$481.6736.54%Hold38.78%20.57%22.11%16.48%
UPC
UNIVERSE PHARMACEUTICALS INC
$14.33M$0.66N/AN/AN/AN/AN/AN/AN/AN/A
QURE
UNIQURE NV
$891.44M$19.11$51.25168.18%Strong Buy4-27.54%N/A-14.87%-10.72%
XNCR
XENCOR INC
$1.61B$27.12$50.0084.37%Strong Buy4-36.58%N/A-18.03%-16.03%
PRTA
PROTHENA CORP PUBLIC LTD CO
$1.30B$27.77$68.67147.27%Strong Buy9-6.36%N/A-5.87%-4.43%
GNFT
GENFIT SA
$168.38M$3.38$9.00166.27%Buy211.14%-9.30%9.62%4.07%
CLSD
CLEARSIDE BIOMEDICAL INC
$99.25M$1.65$10.00506.06%Buy2-26.32%N/A-130.91%-115.10%
BNTX
BIONTECH SE
$32.57B$134.04$291.71117.63%Buy8-49.75%-67.73%-9.63%-7.55%
SELB
SELECTA BIOSCIENCES INC
$201.91M$1.33$5.33300.98%Buy3-34.92%N/A-62.61%-23.97%
NBIX
NEUROCRINE BIOSCIENCES INC
$9.39B$98.24$113.7715.81%Buy1316.77%87.56%49.61%32.18%
IMTX
IMMATICS NV
$539.29M$8.57$26.00203.38%Buy1-50.82%N/A-23.97%-9.85%
AUPH
AURINIA PHARMACEUTICALS INC
$1.59B$11.20$26.00132.14%Buy583.38%N/A50.61%44.74%
VNDA
VANDA PHARMACEUTICALS INC
$604.44M$10.70$12.0012.15%Hold10.72%22.28%7.09%5.90%
CARA
CARA THERAPEUTICS INC
$503.22M$9.39$26.33180.44%Strong Buy3119.31%N/A37.81%34.47%
OPNT
OPIANT PHARMACEUTICALS INC
$64.30M$12.64$42.00232.28%Buy141.70%N/A122.95%80.03%
ATNM
ACTINIUM PHARMACEUTICALS INC
$121.54M$5.11$31.67519.69%Strong Buy4317.97%N/A140.63%129.83%
LOGC
LOGICBIO THERAPEUTICS INC
$14.17M$0.43$5.001,062.79%Strong Buy457.30%N/A41.02%19.69%
RGNX
REGENXBIO INC
$1.14B$26.50$56.67113.84%Strong Buy9-20.88%N/A-34.34%-23.09%
SNDX
SYNDAX PHARMACEUTICALS INC
$1.08B$19.13$29.6755.08%Buy3-0.50%N/A-24.32%-21.58%
VIR
VIR BIOTECHNOLOGY INC
$3.29B$24.84$59.67140.21%Buy6-40.63%N/A-2.71%-1.88%
HCM
HUTCHMED (CHINA) LTD
$2.25B$13.01$49.00276.63%Buy231.94%N/A64.82%46.61%
LUMO
LUMOS PHARMA INC
$61.35M$7.33$28.00281.99%Buy1552.51%N/A-26.90%-23.62%
LPTX
LEAP THERAPEUTICS INC
$106.87M$1.21$5.00313.22%Strong Buy2182.64%N/A-41.22%-38.36%
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
$93.02M$8.39$21.50156.26%Strong Buy1344.63%N/A108.05%95.79%
ABCM
ABCAM PLC
$3.41B$14.88$21.0041.13%Buy615.50%188.20%16.65%11.08%
ZLAB
ZAI LAB LTD
$3.35B$34.22$133.33289.63%Strong Buy372.41%N/AN/AN/A
GANX
GAIN THERAPEUTICS INC
$46.58M$3.92$14.00257.14%Strong Buy249.31%N/A-52.64%-44.56%
RPTX
REPARE THERAPEUTICS INC
$621.71M$14.84$34.40131.81%Strong Buy548.29%N/A-65.76%-50.45%
ADAG
ADAGENE INC
$87.35M$2.00$15.00650.00%Strong Buy172.66%N/A-163.20%-134.82%
FBIO
FORTRESS BIOTECH INC
$94.85M$0.88$9.42966.36%Strong Buy653.08%N/A304.04%72.94%
NVO
NOVO NORDISK A S
$259.00B$112.12N/AN/ABuy414.81%17.23%134.81%45.51%
SEER
SEER INC
$595.70M$9.54$21.00120.13%Hold185.12%N/A-16.30%-15.05%
STTK
SHATTUCK LABS INC
$186.89M$4.41$24.00444.22%Strong Buy3190.12%N/A-46.99%-43.24%
SLRX
SALARIUS PHARMACEUTICALS INC
$10.94M$0.20$4.001,951.28%Buy1292.05%N/A-25.19%-23.71%
ITCI
INTRA-CELLULAR THERAPIES INC
$5.25B$55.62$66.5019.56%Strong Buy681.83%N/A22.49%20.52%
NBRV
NABRIVA THERAPEUTICS PLC
$126.41M$0.20$2.00900.00%Buy146.33%N/A35.41%24.02%
EIGR
EIGER BIOPHARMACEUTICALS INC
$269.67M$6.24$27.00332.69%Strong Buy179.42%N/A-32.43%-20.58%
IMMP
IMMUTEP LTD
$181.93M$2.13$8.15282.63%Strong Buy333.40%N/A-595.40%-539.30%
INMB
INMUNE BIO INC
$146.62M$8.17$10.5028.52%Buy2498.11%N/AN/AN/A
BYSI
BEYONDSPRING INC
$54.11M$1.39$20.001,338.85%Hold4268.08%N/A160.47%52.45%
EYEN
EYENOVIA INC
$61.09M$1.82$14.00669.23%Strong Buy251.52%N/A15.77%11.69%
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
$6.20M$0.65$10.001,433.74%Strong Buy1320.42%N/A-64.02%-61.53%
ALBO
ALBIREO PHARMA INC
$381.15M$19.47$76.67293.77%Buy359.89%N/A77.02%43.68%
IMGN
IMMUNOGEN INC
$950.51M$4.31$7.3370.14%Buy444.39%N/A20.87%13.28%
LMNL
LIMINAL BIOSCIENCES INC
$14.06M$0.45$2.00341.50%Hold3216.04%N/A-34.06%-14.42%
LEXX
LEXARIA BIOSCIENCE CORP
$19.58M$3.29N/AN/AN/AN/A94.40%N/A-45.20%-45.36%
VTGN
VISTAGEN THERAPEUTICS INC
$203.33M$0.98$8.00713.01%Strong Buy2128.24%N/A-76.63%-66.44%
VCYT
VERACYTE INC
$1.62B$22.74$29.8031.05%Buy513.84%N/A-1.98%-1.83%
VRNA
VERONA PHARMA PLC
$270.45M$4.48$22.00391.07%Strong Buy356.87%N/A160.59%119.80%
SIGA
SIGA TECHNOLOGIES INC
$944.18M$13.04N/AN/AN/AN/A-6.09%-14.49%31.08%28.25%
EDIT
EDITAS MEDICINE INC
$924.60M$13.47$52.00286.04%Buy739.11%N/A-38.55%-31.73%
FNCH
FINCH THERAPEUTICS GROUP INC
$130.31M$2.74$17.00520.44%Strong Buy135.25%N/A-56.87%-49.97%
SYBX
SYNLOGIC INC
$79.38M$1.13$7.50563.72%Strong Buy4149.79%N/A-38.23%-31.75%
ORGS
ORGENESIS INC
$62.55M$2.52$9.00257.14%Strong Buy1N/AN/AN/AN/A
IVA
INVENTIVA SA
$264.04M$6.46$42.00550.15%Buy1-48.93%N/A155.23%113.09%
BLI
BERKELEY LIGHTS INC
$391.36M$5.77$11.0090.64%Hold425.40%N/A11.23%8.16%
HSTO
HISTOGEN INC
$5.79M$2.32$1.50-35.34%Buy172.46%N/A-55.57%-36.48%
XENE
XENON PHARMACEUTICALS INC
$1.65B$31.00$43.0038.71%Buy352.75%N/A1.67%1.62%
VCNX
VACCINEX INC
$48.64M$1.14N/AN/AHold11,164.25%N/A324.17%289.59%
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.56B$12.33$23.5090.59%Strong Buy2-36.79%N/A-14.50%-4.13%
RPRX
ROYALTY PHARMA PLC
$26.23B$43.20$49.5714.75%Strong Buy75.99%39.11%26.28%15.34%
CDXS
CODEXIS INC
$747.08M$11.44$30.00162.24%Strong Buy220.29%N/A10.70%7.22%
ITOS
ITEOS THERAPEUTICS INC
$730.72M$20.56$56.50174.81%Buy2-51.24%N/A-39.72%-29.26%
BGNE
BEIGENE LTD
$18.38B$177.99$257.5044.67%Buy255.28%N/A-92.76%-68.06%
BMRN
BIOMARIN PHARMACEUTICAL INC
$16.07B$86.85$101.8617.28%Buy819.54%156.86%18.58%13.46%
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$7.26B$28.45$50.6778.09%Strong Buy3-8.03%-17.02%114.74%21.48%
NVAX
NOVAVAX INC
$4.04B$51.67$187.40262.69%Buy620.65%N/A1,277.44%29.44%
OCUL
OCULAR THERAPEUTIX INC
$306.27M$3.99$18.75369.92%Strong Buy440.10%N/A0.96%0.41%
BLCM
BELLICUM PHARMACEUTICALS INC
$10.42M$1.21$5.00313.22%Strong Buy155.44%N/AN/AN/A
RYTM
RHYTHM PHARMACEUTICALS INC
$219.21M$4.35$21.71399.17%Buy7153.80%N/A-65.19%-53.96%
SGEN
SEAGEN INC
$33.01B$179.33$165.67-7.62%Buy926.24%N/A35.05%29.06%
JANX
JANUX THERAPEUTICS INC
$541.60M$13.01$35.00169.02%Strong Buy3201.68%N/A-38.23%-36.93%
NTRB
NUTRIBAND INC
$30.75M$3.92$14.00257.14%Strong Buy148.86%N/A-17.70%-16.36%
MREO
MEREO BIOPHARMA GROUP PLC
$223.73M$1.53$5.00226.80%Buy1-0.55%N/A-197.00%-137.14%
SYRS
SYROS PHARMACEUTICALS INC
$55.97M$0.89$14.331,508.64%Strong Buy328.41%N/A51.06%21.07%
JNCE
JOUNCE THERAPEUTICS INC
$144.69M$2.80$13.25373.21%Buy585.44%N/A-22.70%-19.98%
MESO
MESOBLAST LTD
$330.16M$2.54$2.50-1.57%Strong Sell1211.32%N/A221.19%167.80%
AVEO
AVEO PHARMACEUTICALS INC
$226.86M$6.58$19.00188.75%Buy158.27%N/A233.32%87.76%
VALN
VALNEVA SE
$1.43B$27.27$56.00105.35%Strong Buy230.97%N/A369.24%77.06%
LQDA
LIQUIDIA CORP
$279.26M$4.34$13.33207.21%Strong Buy388.59%N/A48.79%28.90%
FSTX
F-STAR THERAPEUTICS INC
$137.34M$6.39$21.00228.64%Buy2-19.30%N/A-63.87%-49.09%
TYME
TYME TECHNOLOGIES INC
$41.67M$0.24$9.503,825.62%Strong Buy1N/AN/A163.43%148.70%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Catalyst Pharmaceuticals (NASDAQ:CPRX)


Catalyst Pharmaceuticals (NASDAQ:CPRX) is the top biotech stock with a Zen Score of 74, which is 44 points higher than the biotech industry average of 30. It passed 24 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 12.54% over the past year, overperforming other biotech stocks by 56 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $11.60, an upside of 74.7% from Catalyst Pharmaceuticals's current stock price of $6.64.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Halozyme Therapeutics (NASDAQ:HALO)


Halozyme Therapeutics (NASDAQ:HALO) is the second best biotech stock with a Zen Score of 73, which is 43 points higher than the biotech industry average of 30. It passed 24 out of 33 due diligence checks and has strong fundamentals. Halozyme Therapeutics has seen its stock return 2.96% over the past year, overperforming other biotech stocks by 47 percentage points.

Halozyme Therapeutics has an average 1 year price target of $53.00, an upside of 13.01% from Halozyme Therapeutics's current stock price of $46.90.

Halozyme Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Halozyme Therapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third best biotech stock with a Zen Score of 69, which is 39 points higher than the biotech industry average of 30. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock return 71.66% over the past year, overperforming other biotech stocks by 115 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $58.25, an upside of 12.73% from Harmony Biosciences Holdings's current stock price of $51.67.

Harmony Biosciences Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Harmony Biosciences Holdings, 25% have issued a Strong Buy rating, 75% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 3.45%, which is 2 percentage points higher than the biotech industry average of 1.41%.

Siga Technologies's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.67%, which is the same as the biotech industry average of 1.41%.

Royalty Pharma's dividend payout ratio of 48.6% indicates that its dividend yield is sustainable for the long-term.

3. Biontech Se (NASDAQ:BNTX)


Biontech Se (NASDAQ:BNTX) has an annual dividend yield of 1.57%, which is the same as the biotech industry average of 1.41%.

Biontech Se's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 1.21% in the last day, and up 10.25% over the last week. Beigene was the among the top gainers in the biotechnology industry, gaining 13.95% yesterday.

Shares of Chinese companies are trading higher in sympathy with US markets as well as on continued strength after Chinese President Xi Jinping recently said China would adopt measures to reach its economic targets.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Sesen Bio (NASDAQ:SESN)


Sesen Bio (NASDAQ:SESN) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Sesen Bio has a valuation score of 100, which is 64 points higher than the biotech industry average of 36. It passed 7 out of 7 valuation due diligence checks.

Sesen Bio's stock has dropped -80.48% in the past year. It has underperformed other stocks in the biotech industry by -37 percentage points.

2. Universe Pharmaceuticals (NASDAQ:UPC)


Universe Pharmaceuticals (NASDAQ:UPC) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Universe Pharmaceuticals has a valuation score of 100, which is 64 points higher than the biotech industry average of 36. It passed 7 out of 7 valuation due diligence checks.

Universe Pharmaceuticals's stock has dropped -78.25% in the past year. It has underperformed other stocks in the biotech industry by -35 percentage points.

3. Crispr Therapeutics Ag (NASDAQ:CRSP)


Crispr Therapeutics Ag (NASDAQ:CRSP) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Crispr Therapeutics Ag has a valuation score of 86, which is 50 points higher than the biotech industry average of 36. It passed 6 out of 7 valuation due diligence checks.

Crispr Therapeutics Ag's stock has dropped -51.44% in the past year. It has underperformed other stocks in the biotech industry by -8 percentage points.

Are biotech stocks a good buy now?

51.41% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 124.05% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -2.58x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.